
Does fenbendazole treat cancer?
Checked
Posts and adverts say that fenbendazole, a worming medicine made for animals, can treat or cure cancer.
It is not proven that fenbendazole treats cancer.
What studies show
As of , no study proves that fenbendazole treats cancer. We found 39 published papers on fenbendazole and cancer. They were published between 2017 and 2026. 2 of them are studies in people. 1 of them followed or compared people without deciding who got it (an observational study). Such a study can show a link, but not that one thing causes the other. None of them was a fair test in which chance decided who got it and who did not. 15 were studies in animals, and 8 were only in cells in the lab. 4 papers are reviews that sum up other studies. 1 paper was retracted.
Other studies in people
The only study in people on our list is a 2021 report on three patients. The authors report that the cancer went away in all three. Three patients, with no comparison group, cannot show the medicine caused this.
Reviews
A 2024 review says the medicine is not approved by US or European regulators. So its safety in people is not well documented. The same review says tests in people are needed to see if it works against cancer. A 2025 review and a 2026 review also say tests in people are lacking.
In animals
Several studies in mice report slower tumour growth with fenbendazole. A 2025 study in mice with human lung cancer cells reports more tumours disappearing with a mix of two compounds. Results in animals do not always hold in people.
In the lab
A 2026 cell study reports fenbendazole reduced the survival of ovarian cancer cells. A 2024 study reports it slowed lung cancer cell growth when mixed with another compound.
Other papers
Three case reports from 2025 and 2026 describe liver injury in cancer patients who took fenbendazole themselves. Their liver tests improved after they stopped.
Withdrawn papers
A 2025 report on three patients was withdrawn, so its results cannot be relied on.
What this means for you
Our verdict: Unproven.
The only reports in people are tiny and have no comparison group. Good results so far come from mice and cells, and tests in people are still needed.
Do not stop or change your treatment because of a story about fenbendazole. A study in people is not proof that it helps you. If you are thinking about fenbendazole, talk to your care team first.
This page explains what research has found so far. It is not medical advice. Talk to your doctor before you start, stop or change any treatment.
We searched 19 scientific databases for research from the last 10 years (since 2016. nov. 18.).
Sources
- Public Online Interest In Ivermectin And Fenbendazole For Cancer: Google Trends Analysis Of Educational And Economic Correlates And Implications For Gynecologic Oncology. J Cancer Educ 2026. Observational study in people. PubMed
- What evidence supports the use of fenbendazole in cancer treatment for humans?. Zenodo (CERN European Organization for Nuclear Research) 2026. Review. Zenodo (CERN European Organization for Nuclear Research)
- Ferroptosis Induction by Fenbendazole Combined With Photothermal Therapy Triggers Dual-Immunotherapy Against Bladder Cancer. Adv Sci (Weinh) 2026. In animals. PubMed
- Preferential toxicodynamic effects of fenbendazole in ovarian cancer and nonmalignant ovarian cell models. Drug Chem Toxicol 2026. In the lab. PubMed
- Evaluation of the Drug-Polymer Compatibility and Dissolution Behaviour of Fenbendazole-Soluplus® Solid Dispersions Prepared by Hot-Melt Extrusion. Polymers (Basel) 2026. In the lab. PubMed
- Drug-Induced Liver Injury Following Co-ingestion of Veterinary Fenbendazole and Ivermectin for Prostate Cancer: A Case Report. Cureus 2026. Other paper. PubMed
- Differentiating fenbendazole-induced liver injury from immunotherapy hepatitis - the importance of structured causality assessment: A case report. World J Clin Cases 2026. Other paper. PubMed
- IVERMECTIN, MEBENDAZOLE AND FENBENDAZOLE IN THE TREATMENT OF CANCER. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2025. Review. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
- Fenbendazole Exhibits Antitumor Activity Against Cervical Cancer Through Dual Targeting of Cancer Cells and Cancer Stem Cells: Evidence from In Vitro and In Vivo Models. Molecules 2025. In animals. PubMed
- Synergistic anti-tumor effect of fenbendazole and diisopropylamine dichloroacetate in immunodeficient BALB/c nude mice transplanted with A549 lung cancer cells. Transl Lung Cancer Res 2025. In animals. PubMed
- Fenbendazole induces pyroptosis in breast cancer cells through HK2/caspase-3/GSDME signaling pathway. Front Pharmacol 2025. In animals. PubMed
- [Cholestasis following use of fenbendazole as alternative cancer treatment]. Tidsskr Nor Laegeforen 2025. Other paper. PubMed
- Fenbendazole as an Anticancer Agent? A Case Series of Self-Administration in Three Patients. Case Rep Oncol 2025. Retracted. PubMedRetracted
- Oral Fenbendazole for Cancer Therapy in Humans and Animals. Anticancer Res 2024. Review. PubMed
- Transcriptome analysis reveals the anticancer effects of fenbendazole on ovarian cancer: an in vitro and in vivo study. BMC Cancer 2024. In animals. PubMed
- Fenbendazole and Diisopropylamine Dichloroacetate Exert Synergistic Anti-cancer Effects by Inducing Apoptosis and Arresting the Cell Cycle in A549 Lung Cancer Cells. Anticancer Res 2024. In the lab. PubMed
- Abstract 2313: Fenbendazole induces cell cycle arrest in colorectal cancer cells and patient-derived colon cancer organoids. Cancer Research 2022. In animals. Cancer Research
- Fenbendazole Enhancing Anti-Tumor Effect: A Case Series. Clinical Oncology: Case Reports 2021. Study in people. Clinical Oncology: Case Reports



